Follow this preprint
Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections
View ORCID ProfileA.J. Venkatakrishnan, View ORCID ProfilePraveen Anand, View ORCID ProfilePatrick Lenehan, View ORCID ProfilePritha Ghosh, View ORCID ProfileRohit Suratekar, Abhishek Siroha, Dibyendu Roy Chowdhury, John C. O’Horo, View ORCID ProfileJoseph D. Yao, View ORCID ProfileBobbi S. Pritt, View ORCID ProfileAndrew Norgan, Ryan T. Hurt, View ORCID ProfileAndrew D. Badley, View ORCID ProfileJohn D. Halamka, View ORCID ProfileVenky Soundararajan
doi: https://doi.org/10.1101/2021.05.23.21257668
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
A.J. Venkatakrishnan
1nference, Cambridge, Massachusetts 02139, USA
Praveen Anand
2nference Labs, Bengaluru, Karnataka, India
Patrick Lenehan
1nference, Cambridge, Massachusetts 02139, USA
Pritha Ghosh
2nference Labs, Bengaluru, Karnataka, India
Rohit Suratekar
2nference Labs, Bengaluru, Karnataka, India
Abhishek Siroha
2nference Labs, Bengaluru, Karnataka, India
Dibyendu Roy Chowdhury
1nference, Cambridge, Massachusetts 02139, USA
John C. O’Horo
3Mayo Clinic, Rochester, Minnesota 55902, USA
Joseph D. Yao
3Mayo Clinic, Rochester, Minnesota 55902, USA
Bobbi S. Pritt
3Mayo Clinic, Rochester, Minnesota 55902, USA
Andrew Norgan
3Mayo Clinic, Rochester, Minnesota 55902, USA
Ryan T. Hurt
3Mayo Clinic, Rochester, Minnesota 55902, USA
Andrew D. Badley
3Mayo Clinic, Rochester, Minnesota 55902, USA
John D. Halamka
3Mayo Clinic, Rochester, Minnesota 55902, USA
Venky Soundararajan
1nference, Cambridge, Massachusetts 02139, USA
2nference Labs, Bengaluru, Karnataka, India

Posted June 14, 2021.
Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections
A.J. Venkatakrishnan, Praveen Anand, Patrick Lenehan, Pritha Ghosh, Rohit Suratekar, Abhishek Siroha, Dibyendu Roy Chowdhury, John C. O’Horo, Joseph D. Yao, Bobbi S. Pritt, Andrew Norgan, Ryan T. Hurt, Andrew D. Badley, John D. Halamka, Venky Soundararajan
medRxiv 2021.05.23.21257668; doi: https://doi.org/10.1101/2021.05.23.21257668
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
2
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
1
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (410)
- Allergy and Immunology (725)
- Anesthesia (214)
- Cardiovascular Medicine (3086)
- Dermatology (260)
- Emergency Medicine (462)
- Epidemiology (13014)
- Forensic Medicine (13)
- Gastroenterology (860)
- Genetic and Genomic Medicine (4834)
- Geriatric Medicine (445)
- Health Economics (750)
- Health Informatics (3057)
- Health Policy (1101)
- Hematology (410)
- HIV/AIDS (956)
- Medical Education (453)
- Medical Ethics (119)
- Nephrology (499)
- Neurology (4606)
- Nursing (244)
- Nutrition (684)
- Oncology (2385)
- Ophthalmology (673)
- Orthopedics (268)
- Otolaryngology (333)
- Pain Medicine (300)
- Palliative Medicine (87)
- Pathology (514)
- Pediatrics (1239)
- Primary Care Research (520)
- Public and Global Health (7189)
- Radiology and Imaging (1601)
- Respiratory Medicine (943)
- Rheumatology (459)
- Sports Medicine (403)
- Surgery (509)
- Toxicology (65)
- Transplantation (221)
- Urology (189)